 Anthony Gerber
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 17 | 2025 | 155 | 4.970 |
Why?
| | Glucocorticoids | 13 | 2025 | 594 | 2.800 |
Why?
| | Dexamethasone | 10 | 2022 | 368 | 2.230 |
Why?
| | Transcription, Genetic | 9 | 2025 | 1457 | 1.750 |
Why?
| | Kruppel-Like Transcription Factors | 7 | 2020 | 66 | 1.710 |
Why?
| | NF-kappa B | 11 | 2025 | 691 | 1.690 |
Why?
| | Muscle, Smooth | 4 | 2019 | 155 | 1.520 |
Why?
| | Asthma | 12 | 2025 | 2295 | 1.430 |
Why?
| | Nuclear Proteins | 6 | 2017 | 712 | 1.350 |
Why?
| | Enhancer Elements, Genetic | 5 | 2025 | 190 | 1.290 |
Why?
| | Gene Expression Regulation | 14 | 2025 | 2607 | 1.220 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2024 | 1242 | 1.140 |
Why?
| | Transcription Factors | 4 | 2022 | 1719 | 1.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 3 | 2025 | 55 | 0.970 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 496 | 0.960 |
Why?
| | Airway Remodeling | 2 | 2017 | 64 | 0.890 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 4 | 2016 | 11 | 0.880 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 3 | 2025 | 243 | 0.870 |
Why?
| | Alveolar Epithelial Cells | 2 | 2022 | 114 | 0.860 |
Why?
| | Transcription Factor RelA | 4 | 2025 | 87 | 0.800 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2025 | 657 | 0.750 |
Why?
| | Mucin-5B | 3 | 2022 | 224 | 0.740 |
Why?
| | Signal Transduction | 11 | 2021 | 5079 | 0.730 |
Why?
| | Wood | 1 | 2021 | 16 | 0.730 |
Why?
| | Inflammation | 6 | 2022 | 2837 | 0.670 |
Why?
| | Smoke | 1 | 2021 | 141 | 0.660 |
Why?
| | Particulate Matter | 1 | 2022 | 315 | 0.640 |
Why?
| | Respiratory System | 2 | 2017 | 157 | 0.610 |
Why?
| | RNA | 2 | 2025 | 921 | 0.610 |
Why?
| | Bronchi | 3 | 2018 | 260 | 0.600 |
Why?
| | Repressor Proteins | 2 | 2021 | 427 | 0.590 |
Why?
| | Epithelial Cells | 5 | 2024 | 1096 | 0.590 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2025 | 2189 | 0.590 |
Why?
| | Hyperoxia | 1 | 2019 | 90 | 0.590 |
Why?
| | Proline Oxidase | 2 | 2015 | 6 | 0.580 |
Why?
| | Response Elements | 2 | 2015 | 91 | 0.560 |
Why?
| | Phospholipase C delta | 1 | 2017 | 5 | 0.560 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.540 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 1040 | 0.540 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1502 | 0.540 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 565 | 0.510 |
Why?
| | Cell Line | 8 | 2021 | 2847 | 0.510 |
Why?
| | Cytokines | 4 | 2025 | 2085 | 0.490 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 395 | 0.490 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.480 |
Why?
| | Homeodomain Proteins | 2 | 2018 | 506 | 0.470 |
Why?
| | Triage | 1 | 2017 | 222 | 0.470 |
Why?
| | Lung | 8 | 2024 | 4060 | 0.440 |
Why?
| | RNA, Messenger | 4 | 2020 | 2833 | 0.430 |
Why?
| | Genes, Reporter | 2 | 2017 | 269 | 0.420 |
Why?
| | Gene Expression | 3 | 2022 | 1502 | 0.400 |
Why?
| | Prednisolone | 1 | 2013 | 83 | 0.400 |
Why?
| | Drug Discovery | 2 | 2016 | 142 | 0.400 |
Why?
| | RNA Polymerase II | 5 | 2021 | 324 | 0.400 |
Why?
| | Introns | 1 | 2014 | 258 | 0.400 |
Why?
| | Chromatin | 3 | 2022 | 519 | 0.390 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 220 | 0.390 |
Why?
| | Machine Learning | 1 | 2017 | 493 | 0.380 |
Why?
| | Binding Sites | 5 | 2021 | 1303 | 0.380 |
Why?
| | Humans | 45 | 2025 | 137585 | 0.370 |
Why?
| | Genomics | 3 | 2022 | 795 | 0.370 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 455 | 0.340 |
Why?
| | A549 Cells | 4 | 2025 | 66 | 0.330 |
Why?
| | Bronchial Hyperreactivity | 1 | 2011 | 111 | 0.330 |
Why?
| | Protein Binding | 6 | 2020 | 2224 | 0.310 |
Why?
| | Chromatin Immunoprecipitation | 4 | 2017 | 138 | 0.300 |
Why?
| | I-kappa B Kinase | 3 | 2024 | 55 | 0.290 |
Why?
| | Vitamin D | 1 | 2011 | 397 | 0.290 |
Why?
| | Models, Genetic | 2 | 2021 | 600 | 0.290 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 2 | 2018 | 37 | 0.270 |
Why?
| | Cells, Cultured | 5 | 2019 | 4193 | 0.270 |
Why?
| | Transcriptional Activation | 3 | 2016 | 378 | 0.270 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 261 | 0.260 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 660 | 0.260 |
Why?
| | Animals | 14 | 2025 | 36940 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2426 | 0.250 |
Why?
| | Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2025 | 4 | 0.240 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2025 | 49 | 0.240 |
Why?
| | Systems Biology | 1 | 2006 | 67 | 0.240 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 480 | 0.240 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 1250 | 0.240 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2526 | 0.230 |
Why?
| | Lung Diseases | 2 | 2015 | 767 | 0.230 |
Why?
| | Base Sequence | 4 | 2017 | 2181 | 0.220 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 321 | 0.210 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 332 | 0.200 |
Why?
| | Transposases | 1 | 2022 | 19 | 0.190 |
Why?
| | Afghanistan | 1 | 2022 | 71 | 0.190 |
Why?
| | Mice | 7 | 2021 | 17787 | 0.190 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2021 | 9 | 0.190 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2021 | 32 | 0.180 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 145 | 0.180 |
Why?
| | Biological Therapy | 2 | 2022 | 29 | 0.180 |
Why?
| | alpha 1-Antitrypsin | 1 | 2022 | 108 | 0.180 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 144 | 0.180 |
Why?
| | Air Pollution | 1 | 2025 | 316 | 0.180 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 115 | 0.180 |
Why?
| | PPAR gamma | 1 | 2022 | 182 | 0.170 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 36 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 283 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.170 |
Why?
| | Respiratory Tract Diseases | 1 | 2022 | 184 | 0.170 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 104 | 0.170 |
Why?
| | Primary Cell Culture | 2 | 2019 | 171 | 0.170 |
Why?
| | Congresses as Topic | 2 | 2024 | 233 | 0.160 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 252 | 0.160 |
Why?
| | Corynebacterium Infections | 1 | 2020 | 41 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.150 |
Why?
| | Gene Silencing | 2 | 2016 | 195 | 0.150 |
Why?
| | Fluticasone | 1 | 2018 | 90 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 528 | 0.140 |
Why?
| | Male | 10 | 2025 | 67762 | 0.140 |
Why?
| | Mucins | 1 | 2018 | 73 | 0.140 |
Why?
| | Histidine Decarboxylase | 1 | 2017 | 5 | 0.140 |
Why?
| | Microphthalmia-Associated Transcription Factor | 1 | 2017 | 14 | 0.140 |
Why?
| | Drug Resistance | 1 | 2018 | 169 | 0.140 |
Why?
| | GATA2 Transcription Factor | 1 | 2017 | 15 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2019 | 189 | 0.140 |
Why?
| | Regeneration | 1 | 2019 | 197 | 0.130 |
Why?
| | Hypertrophy | 1 | 2017 | 133 | 0.130 |
Why?
| | Transduction, Genetic | 1 | 2017 | 127 | 0.130 |
Why?
| | Trachea | 1 | 2018 | 237 | 0.130 |
Why?
| | HEK293 Cells | 1 | 2019 | 730 | 0.130 |
Why?
| | Female | 9 | 2025 | 73304 | 0.130 |
Why?
| | Statistics as Topic | 1 | 2017 | 307 | 0.130 |
Why?
| | Feedback, Physiological | 1 | 2016 | 77 | 0.130 |
Why?
| | Adenoviridae | 1 | 2017 | 193 | 0.130 |
Why?
| | Mast Cells | 1 | 2017 | 147 | 0.130 |
Why?
| | Anaphylaxis | 1 | 2017 | 105 | 0.130 |
Why?
| | Lung Injury | 1 | 2019 | 219 | 0.120 |
Why?
| | Models, Biological | 4 | 2016 | 1783 | 0.120 |
Why?
| | Fibroblasts | 2 | 2025 | 996 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2019 | 6079 | 0.120 |
Why?
| | Drug Monitoring | 1 | 2016 | 218 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2018 | 789 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 86 | 0.120 |
Why?
| | Administration, Inhalation | 1 | 2016 | 688 | 0.110 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2015 | 89 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 322 | 0.110 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 452 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 665 | 0.110 |
Why?
| | Disease Progression | 2 | 2023 | 2757 | 0.110 |
Why?
| | Consensus | 1 | 2017 | 683 | 0.110 |
Why?
| | Cohort Studies | 1 | 2025 | 5742 | 0.110 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.110 |
Why?
| | Pulmonary Surfactants | 1 | 2015 | 106 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 976 | 0.110 |
Why?
| | Muscle, Skeletal | 2 | 2015 | 1724 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 106 | 0.110 |
Why?
| | Blotting, Western | 1 | 2016 | 1226 | 0.100 |
Why?
| | Mice, Inbred C57BL | 3 | 2015 | 5757 | 0.100 |
Why?
| | Interleukin-1beta | 2 | 2025 | 372 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 70 | 0.100 |
Why?
| | Immunotherapy | 1 | 2017 | 641 | 0.090 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 305 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 429 | 0.090 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 126 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 539 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2020 | 622 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2018 | 940 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1774 | 0.090 |
Why?
| | Transcriptome | 1 | 2017 | 971 | 0.090 |
Why?
| | Antibody Formation | 2 | 2022 | 298 | 0.090 |
Why?
| | Ovalbumin | 1 | 2011 | 183 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2900 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3412 | 0.080 |
Why?
| | Mice, Knockout | 2 | 2017 | 3015 | 0.080 |
Why?
| | Algorithms | 1 | 2017 | 1704 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1430 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3284 | 0.080 |
Why?
| | Middle Aged | 2 | 2025 | 33479 | 0.080 |
Why?
| | Caproates | 1 | 2009 | 4 | 0.080 |
Why?
| | Aurintricarboxylic Acid | 1 | 2009 | 4 | 0.080 |
Why?
| | Toluidines | 1 | 2009 | 7 | 0.080 |
Why?
| | Budesonide | 2 | 2022 | 89 | 0.080 |
Why?
| | Rosaniline Dyes | 1 | 2009 | 13 | 0.080 |
Why?
| | Anthracyclines | 1 | 2009 | 42 | 0.080 |
Why?
| | Physicians | 1 | 2017 | 910 | 0.080 |
Why?
| | Adipogenesis | 1 | 2009 | 55 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 767 | 0.070 |
Why?
| | Biomarkers | 2 | 2017 | 4149 | 0.070 |
Why?
| | Lipid Metabolism | 1 | 2012 | 518 | 0.070 |
Why?
| | Biological Assay | 1 | 2009 | 124 | 0.070 |
Why?
| | Antibodies, Viral | 2 | 2022 | 625 | 0.070 |
Why?
| | Autonomic Nervous System | 2 | 2005 | 75 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 886 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2009 | 321 | 0.070 |
Why?
| | Ligands | 1 | 2009 | 664 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2167 | 0.060 |
Why?
| | Tobacco, Smokeless | 1 | 2005 | 13 | 0.060 |
Why?
| | DNA Methylation | 2 | 2022 | 643 | 0.060 |
Why?
| | Drug Therapy | 1 | 2005 | 85 | 0.060 |
Why?
| | Macrophages | 2 | 2022 | 1547 | 0.060 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2025 | 175 | 0.050 |
Why?
| | Disease | 1 | 2005 | 98 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2475 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 13 | 0.050 |
Why?
| | Environment | 1 | 2005 | 358 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 58 | 0.050 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2005 | 179 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 47 | 0.050 |
Why?
| | Phenotype | 2 | 2024 | 3196 | 0.050 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 402 | 0.050 |
Why?
| | Nicotine | 1 | 2005 | 334 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 405 | 0.050 |
Why?
| | Adult | 1 | 2025 | 37929 | 0.050 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 67 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2016 | 10811 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 380 | 0.040 |
Why?
| | Exercise | 1 | 2012 | 2057 | 0.040 |
Why?
| | Young Adult | 1 | 2016 | 13209 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 991 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 558 | 0.040 |
Why?
| | Corynebacterium | 1 | 2020 | 49 | 0.040 |
Why?
| | Keratinocytes | 1 | 2020 | 249 | 0.040 |
Why?
| | Th1 Cells | 1 | 2018 | 143 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 181 | 0.030 |
Why?
| | Transfection | 1 | 2020 | 945 | 0.030 |
Why?
| | Formoterol Fumarate | 1 | 2016 | 7 | 0.030 |
Why?
| | Smoking | 1 | 2005 | 1627 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 157 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 21513 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 327 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 313 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 342 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1459 | 0.030 |
Why?
| | Canada | 1 | 2017 | 418 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1759 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 683 | 0.030 |
Why?
| | Eosinophils | 1 | 2017 | 332 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2057 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1060 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1381 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 740 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1483 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5647 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10388 | 0.020 |
Why?
| | United States | 2 | 2017 | 14841 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4295 | 0.020 |
Why?
| | Amino Acids | 1 | 2012 | 497 | 0.020 |
Why?
| | Homeostasis | 1 | 2012 | 621 | 0.020 |
Why?
| | Glucose | 1 | 2012 | 1020 | 0.020 |
Why?
| | Tachycardia | 1 | 2005 | 57 | 0.010 |
Why?
| | Tumor Escape | 1 | 2005 | 42 | 0.010 |
Why?
| | Biological Clocks | 1 | 2005 | 45 | 0.010 |
Why?
| | Vagus Nerve | 1 | 2005 | 86 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 182 | 0.010 |
Why?
| | Th2 Cells | 1 | 2005 | 176 | 0.010 |
Why?
| | Melatonin | 1 | 2005 | 150 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11074 | 0.010 |
Why?
| | Receptors, Nicotinic | 1 | 2005 | 334 | 0.010 |
Why?
| | Life Style | 1 | 2005 | 490 | 0.010 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2005 | 165 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2005 | 468 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2005 | 442 | 0.010 |
Why?
| | Child | 1 | 2018 | 21935 | 0.010 |
Why?
| | Anxiety | 1 | 2005 | 1035 | 0.010 |
Why?
| | Hypertension | 1 | 2005 | 1295 | 0.010 |
Why?
| | Neoplasms | 1 | 2005 | 2671 | 0.000 |
Why?
|
|
Gerber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|